Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Business News/Market/Market Stats/Suven Pharmaceuticals share price/ Suven Pharmaceuticals Balance Sheet Annual
Suven Pharmaceuticals Balance Sheet Annual
Trade1,275.05 -19.30 (-1.49%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Cash | 47.23 | 64.80 | 44.56 | 7.18 |
| Cash Equivalents | 3.27 | - | - | - |
| Short Term Investments | 774.32 | 421.09 | 483.37 | 182.64 |
| Cashand Short Term Investments | 824.82 | 485.89 | 527.94 | 189.82 |
| Accounts Receivable- Trade Net | 133.66 | 111.22 | 236.37 | 102.38 |
| Total Receivables Net | 144.47 | 184.89 | 292.99 | 157.42 |
| Total Inventory | 231.20 | 330.58 | 300.02 | 212.72 |
| Other Current Assets Total | 62.69 | 1.06 | 0.59 | 0.43 |
| Total Current Assets | 1,263.19 | 1,011.05 | 1,127.93 | 564.79 |
| Property/ Plant/ Equipment Total- Net | 786.78 | 766.22 | 561.95 | 534.89 |
| Intangibles Net | 61.93 | 62.19 | 2.24 | 2.59 |
| Long Term Investments | 139.95 | 117.10 | 117.10 | 361.19 |
| Note Receivable- Long Term | 0.01 | 3.27 | 13.07 | 11.01 |
| Other Long Term Assets Total | 2.24 | 5.91 | 7.30 | - |
| Total Assets | 2,254.09 | 1,965.74 | 1,829.59 | 1,474.47 |
| Accounts Payable | 42.36 | 65.16 | 105.90 | 82.93 |
| Current Portof LT Debt/ Capital Leases | 43.76 | 20.48 | 21.09 | 21.07 |
| Other Currentliabilities Total | 20.78 | 28.52 | 36.17 | 30.11 |
| Total Current Liabilities | 106.90 | 158.77 | 210.29 | 219.75 |
| Capital Lease Obligations | 21.24 | 0.70 | 0.46 | 0.74 |
| Total Long Term Debt | 21.24 | 5.26 | 28.90 | 36.33 |
| Total Debt | 65.00 | 70.34 | 97.13 | 143.04 |
| Deferred Income Tax | 64.79 | 58.23 | 54.32 | 30.93 |
| Other Liabilities Total | 10.50 | 8.30 | 8.89 | 6.65 |
| Total Liabilities | 203.42 | 230.56 | 302.41 | 293.66 |
| Common Stock Total | 25.46 | 25.46 | 25.46 | 25.46 |
| Other Equity Total | 2,025.21 | - | 6.49 | 15.01 |
| Total Equity | 2,050.66 | 1,735.18 | 1,527.18 | 1,180.81 |
| Total Liabilities Shareholders' Equity | 2,254.09 | 1,965.74 | 1,829.59 | 1,474.47 |
| Total Common Shares Outstanding | 25.46 | 25.46 | 25.46 | 25.46 |
| Tangible Book Valueper Share Common Eq | 78.12 | 65.72 | 59.90 | 46.28 |
| Prepaid Expenses | - | 8.63 | 6.40 | 4.40 |
| Property/ Plant/ Equipment Total- Gross | - | 976.32 | 719.80 | 661.11 |
| Accumulated Depreciation Total | - | -210.10 | -157.84 | -126.22 |
| Notes Payable/ Short Term Debt | - | 44.60 | 47.13 | 85.64 |
| Long Term Debt | - | 4.56 | 28.44 | 35.59 |
| Additional Paid- In Capital | - | 109.57 | 109.57 | 109.57 |
| Retained Earnings( Accumulated Deficit) | - | 1,589.44 | 1,385.66 | 1,030.77 |
| Unrealized Gain( Loss) | - | 10.72 | - | - |
*All figures in crores except per share values
Suven Pharmaceuticals Quick Links
Suven Pharmaceuticals Dividend Suven Pharmaceuticals Bonus Suven Pharmaceuticals News Suven Pharmaceuticals AGM Suven Pharmaceuticals Rights Suven Pharmaceuticals Splits Suven Pharmaceuticals Board Meetings Suven Pharmaceuticals Key Metrics Suven Pharmaceuticals Shareholdings Suven Pharmaceuticals Profit Loss Suven Pharmaceuticals Cashflow Suven Pharmaceuticals Q1 Results Suven Pharmaceuticals Q2 Results Suven Pharmaceuticals Q3 Results Suven Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)